Cargando…

Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression

Detalles Bibliográficos
Autores principales:	Fontana, Fabrizio, Anselmi, Martina, Limonta, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997078/ https://www.ncbi.nlm.nih.gov/pubmed/35406386 http://dx.doi.org/10.3390/cancers14071614

Ejemplares similares

Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
por: Fontana, Fabrizio, et al.
Publicado: (2022)

Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer
por: Fontana, Fabrizio, et al.
Publicado: (2023)

Adipocytes reprogram prostate cancer stem cell machinery
por: Fontana, Fabrizio, et al.
Publicado: (2023)

Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression
por: Anselmi, Martina, et al.
Publicado: (2022)

Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes
por: Fontana, Fabrizio, et al.
Publicado: (2022)

Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Drug-resistant tuberculosis: Promising progress with a note of caution
por: Esmail, Hanif, et al.
Publicado: (2022)

Cancer Stem Cells—Key Players in Tumor Relapse
por: Marzagalli, Monica, et al.
Publicado: (2021)

In Vitro 3D Cultures to Model the Tumor Microenvironment
por: Fontana, Fabrizio, et al.
Publicado: (2021)

We shall overcome (drug resistance) some day
por: Sharma, Geeta G., et al.
Publicado: (2019)

Overcoming drug resistance in glioblastoma: new options in sight?
por: Kopecka, Joanna, et al.
Publicado: (2021)

Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
por: Fontana, Fabrizio, et al.
Publicado: (2020)

Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor
por: Serrano, César, et al.
Publicado: (2019)

Targeting DNA repair pathways to overcome cancer drug resistance
por: van Waardenburg, Robert C.A.M., et al.
Publicado: (2021)

Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
por: Fontana, Fabrizio, et al.
Publicado: (2020)

Exosomes in Genitourinary Cancers: Emerging Mediators of Drug Resistance and Promising Biomarkers
por: Lu, Zeyi, et al.
Publicado: (2023)

Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer
por: Armstrong, Cameron M., et al.
Publicado: (2016)

Progress and promise
por: Schekman, Randy
Publicado: (2019)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis
por: Stelitano, Giovanni, et al.
Publicado: (2020)

Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
por: Innao, Vanessa, et al.
Publicado: (2021)

Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance
por: Hassanin, Islam, et al.
Publicado: (2020)

Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches
por: Cheng, Xiaofei, et al.
Publicado: (2023)

Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
por: Chu, Yu-Yi, et al.
Publicado: (2022)

Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
por: Marzagalli, Monica, et al.
Publicado: (2016)

Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
por: Fontana, Fabrizio, et al.
Publicado: (2020)

Biomarkers in Emergency Medicine
por: Cardelli, Patrizia, et al.
Publicado: (2018)

CC Chemokine Ligand-2: A Promising Target for Overcoming Anticancer Drug Resistance
por: Shi, Zhenbo, et al.
Publicado: (2022)

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
por: Song, Xiaohai, et al.
Publicado: (2023)

The Importance of Overcoming Resistance
por: Paradis, Norman A.
Publicado: (2020)

BETting on combination to overcome PARPi resistance
por: Zhang, Youyou, et al.
Publicado: (2017)

Implementation of Precision Cancer Medicine: Progress and the Path to Realizing the Promise of Tumor Sequencing
por: Bradbury, Angela R.
Publicado: (2019)

Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma
por: Davis, Lorraine N., et al.
Publicado: (2021)

Promises and caveats of in silico biomarker discovery
por: Pusztai, L, et al.
Publicado: (2008)

The Promising Biomarker for Multiple Clinical Situations
por: Sadeghi, Mohammad Reza
Publicado: (2014)

Presepsin: A Promising Biomarker for Sepsis
por: Azim, Afzal
Publicado: (2021)

Stem Cell Research: Promise and Progress
por: Jaenisch, Rudolf
Publicado: (2015)

IgY antibodies: The promising potential to overcome antibiotic resistance
por: El-Kafrawy, Sherif A., et al.
Publicado: (2023)

Microalgae: A Promising Future
por: Caroppo, Carmela, et al.
Publicado: (2022)

Remodeling tumor microenvironment with natural products to overcome drug resistance
por: Zhang, Wanlu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tvffacsu5pkor1nea56so97n24